Abstract. Calcium absorption decreases with aging, particularly after age 70 yr. We investigated the possibility that this was due to abnormal vitamin D metabolism by studying 10 normal premenopausal women for the enzyme 25(OH)D la-hydroxylase, correlated inversely with age (r = -0.58; P < 0.001) and directly with glomerular filtration rate (r = 0.64; P < 0.001). The response was more blunted (P = 0.01) in elderly patients with hip fracture (13±3 pg/ml) than in elderly controls (25±3 pg/ml). We conclude that an impaired ability of the aging kidney to synthesize 1,25(OH)2D could contribute to the pathogenesis of senile osteoporosis.
Introduction
Everyone loses bone with aging, and women lose more than men (1, 2) . This decrease in bone mass is associated with an age-related increase in parathyroid function (3) (4) (5) . In women, Received for publication 12 December 1983 and in revised form 23 January 1984. increases in serum immunoreactive parathyroid hormone (iPTH)' and in bone turnover (assessed by measurement of serum bone Gla-protein and other biochemical markers [6] ) are correlated. Aging is also associated with a decrease in intestinal calcium absorption that is large enough to account for the observed increase in parathyroid function (7) (8) (9) . Thus, a better understanding of the cause of the decreased calcium absorption could lead to a better understanding of the mechanism of agerelated bone loss.
The vitamin D-endocrine system is the most important regulator of intestinal calcium absorption. Vitamin D undergoes sequential hydroxylation at C-25 in the liver and at C-l in the kidney to produce 1,25-dihydroxyvitamin D [1,25(OH)2D], a major, physiologically active form of the vitamin (10) . We undertook the present study to 
Methods
Subjects and experimental protocol. We studied four groups of women: group A, 10 normal premenopausal women, age, 37±4 yr (mean±SD); group B, 8 normal women within 20 yr of menopause, 61±6 yr; group C, 10 normal elderly women, 78±4 yr; and group D, 8 elderly women with fracture of the proximal femur, 78±4 yr. None of the normal subjects had a history of nontraumatic fractures, and everyone older than 50 had roentgenograms of the spinal column that showed no vertebral fractures, and bone mineral density values of the lumbar spine (by dual photon absorptiometry) that were within the age-adjusted normal range. In group D, the hip fracture had occurred more than 6 mo before the study and resulted from a fall from a position no higher than standing. (11) . This radioimmunoassay incorporated GP-IM, an antiserum that reacts primarily with determinants in the 44-68 region of the PTH molecule, which is particularly sensitive to increased PTH secretion (4) . Glomerular filtration rate (GFR) was calculated from 24-h creatinine clearance corrected to a body surface area of 1.73 M2. Statistical analysis. The relationship of variables with age or GFR was assessed by linear regression analysis. Multiple regression analysis including partial correlation coefficients was used to determine the association of variables with age after holding GFR constant and vice versa. A Clinfo software package was used for these analyses. The analysis of covariance, with age and GFR as covariates, was used to compare the four groups. The two-tailed t test for independent samples was used to compare parameters in different groups after the analysis of variance demonstrated the presence of differences among groups. A canonical correlation analysis (15) was used to assess the linear relationship of age and GFR, taken as one set, and the remaining variables, taken as the other set. The SAS software package (SAS Institute, Inc., Raleigh, NC) (16) was used to perform these latter analyses.
Results
Values for laboratory measurements are given in Table I and their statistical significance is shown in Table II . Compared with the younger women (groups A and B), the elderly women had lower values for GFR, basal serum 1,25(OH)2D, and incremental increase in serum 1,25(OH)2D after bPTH(1-34) infusion. The elderly women with hip fracture (group D) had lower values for the incremental increase in serum 1,25(OH)2D than did the elderly normal women. This difference remained significant (P (Fig. 1) . It correlated directly with GFR (Fig. 2) , and responses were poorest in subjects who had values for GFR < 60 ml/min per 1.73 M2. With multiple linear regression analysis (Table IV) We studied the mechanism of the age-related decrease in serum levels of 1 ,25(OH)2D by assessing the effect of exogenous infusion of PTH, a tropic agent for renal 25(OH)D a-hydroxylase (19) . Our findings suggest a primary impairment of enzyme function, as has been reported in aging rats (20, 21 (22) may be an important determinant of this abnormality. The increase in urinary cAMP excretion after bPTH( 1-34) infusion in the elderly subjects, however, was equivalent to that of the younger subjects.
Our hypothesis is that the decreased production of 1,25(OH)2D by the aging kidney results in a decrease in intestinal calcium absorption, which in turn causes increased PTH secretion. The PTH then causes increased bone turnover. Because the elderly also have decreased bone formation at the cellular level (23) (less bone is formed than is resorbed at each individual bone remodeling unit), an increase in bone turnover (and, thus, in the activation of new bone remodeling units) would lead to an increase in bone loss. That the impairment in 25(OH)D 1 ahydroxylase reserve capacity was more severe in elderly women with hip fractures than in age-matched controls further supports this hypothesis.
Our results apply only to patients with senile osteoporosis and not to patients with postmenopausal osteoporosis; there is growing evidence that these are distinct syndromes (24) . In contrast with the findings reported here, both Riggs et al. (25) and Sorensen et al. (26) found that the increase in serum 1,25(OH)2D after administration of parathyroid extract in women with postmenopausal osteoporosis did not differ from that in age-matched postmenopausal women without osteoporosis. Although serum 1,25(OH)2D levels are decreased in both osteoporosis syndromes (17) , the decrease in 25(OH)D I a-hydroxylase activity in patients with postmenopausal osteoporosis appears to be secondary to a decrease in PTH secretion as a result of accelerated loss of bone, whereas the reduction in enzyme function in patients 1671 Impaired Vitamin D Metabolism with Aging in Women with senile osteoporosis may be a primary defect that ultimately causes increased parathyroid function. Slovik et al. (27) reported that six normal women and men (mean age, 29 yr) had a greater increase in serum 1,25(OH)2D after PTH infusion than did five osteoporotic women and men (mean age, 58 yr) with vertebral fractures. Because their groups were not age-matched, however, this could have been an age effect. Senile osteoporosis traditionally has been attributed to bone cell senescence and, thus, has been considered not to be amenable to therapy. We have documented a potentially treatable (28) abnormality of vitamin D metabolism, which could contribute to age-related bone loss. It is now appropriate to determine whether impaired calcium absorption in elderly women can be corrected by treatment with a small dose of 1,25(0H)2D and, if so, whether this reduces their bone loss.
